James Bylund is Chief Operating Officer of REPLIGEN CORP. Currently has a direct ownership of 23,711 shares of RGEN, which is worth approximately $3.02 Million. The most recent transaction as insider was on Feb 24, 2022, when has been sold 188 shares (Common Stock) at a price of $189.21 per share, resulting in proceeds of $35,571. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
15.15% 12M change
Total Value Held $3.02 Million

James Bylund Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2022
SELL
Payment of exercise price or tax liability
$35,571 $189.21 p/Share
188 Reduced 1.83%
10,068 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
3,366 Added 24.71%
10,256 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$60,928 $182.42 p/Share
334 Reduced 4.62%
6,890 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
900 Added 11.08%
7,224 Common Stock
Apr 06 2021
SELL
Open market or private sale
$73,530 $204.25 p/Share
360 Reduced 5.39%
6,324 Common Stock
JB

James Bylund

Chief Operating Officer
Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN